Aripra Tablet

Introduction

Aripra Tablet 15 mg is an atypical antipsychotic medication used primarily for the treatment of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. It is known for its unique pharmacological profile, which includes partial agonism at dopamine D2 receptors and serotonin 5-HT1A receptors, and antagonism at serotonin 5-HT2A receptors.

Uses

Aripra Tablet 15 mg is used to treat:

Schizophrenia in adults and adolescents aged 13-17 years.
Bipolar I disorder in adults and adolescents aged 10-17 years.
Major depressive disorder as an adjunct to antidepressant therapy in adults.
Tourette's disorder and irritability associated with autistic disorder in children and adolescents (specific formulations).

Brand Name	Aripra
Type	Tablet
Weight	15 mg
Generic	Aripiprazole
Manufacturer	Incepta Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Aripra Tablet 15 mg works through a combination of partial agonism and antagonism at various neurotransmitter receptors. It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, which helps to stabilize dopamine and serotonin activity. It also antagonizes serotonin 5-HT2A receptors. This balanced action helps to improve symptoms of psychosis and mood disorders while minimizing some of the side effects commonly associated with other antipsychotics.

How Long Does It Take to Work?

Aripra Tablet 15 mg typically begins to show its effects within 1-2 weeks of initiation. However, it may take 4-6 weeks to achieve full therapeutic effects, especially in the treatment of mood disorders or schizophrenia.

Absorption

Aripra Tablet 15 mg is well absorbed following oral administration, with peak plasma concentrations occurring within 3-5 hours. Food does not significantly affect the absorption of aripiprazole.

Route of Elimination

Aripra Tablet 15 mg is primarily metabolized by the liver through the cytochrome P450 enzyme system, particularly CYP2D6 and CYP3A4. It is excreted mainly in the urine (approximately 60%) and feces (approximately 40%).

Dosage

Schizophrenia: adults

Initial Dose: 10-15 mg/day
Recommended Dose: 10-15 mg/day
Maximum Dose: 30 mg/day

Schizophrenia: adolescents (ages 13-17 years)

Initial Dose: 2 mg/day
Recommended Dose: 10 mg/day
Maximum Dose: 30 mg/day

Bipolar mania: adults: monotherapy

Initial Dose: 15 mg/day
Recommended Dose: 15 mg/day
Maximum Dose: 30 mg/day

Bipolar mania: adults: adjunct to lithium or valproate

Initial Dose: 10-15 mg/day
Recommended Dose: 15 mg/day
Maximum Dose: 30 mg/day

Bipolar mania: pediatric patients (ages 10-17 years): monotherapy or as an adjunct to lithium or valproate

Initial Dose: 2 mg/day
Recommended Dose: 10 mg/day
Maximum Dose: 30 mg/day

As an adjunct to antidepressants for the treatment of major depressive disorder: adults

Initial Dose: 2-5 mg/day
Recommended Dose: 5-10 mg/day
Maximum Dose: 15 mg/day

Irritability associated with autistic disorder: pediatric patients (ages 6-17 years):

Initial Dose: 2 mg/day
Recommended Dose: 5-10 mg/day
Maximum Dose: 15 mg/day

The typical dosage for aripiprazole is:

Schizophrenia: 10-15 mg once daily, with a maximum dose of 30 mg/day.
Bipolar I disorder: 15-30 mg once daily.
Major depressive disorder: 2-15 mg once daily as an adjunctive treatment.
Tourette's disorder: 5-10 mg/day, adjusted based on response and tolerability.
Irritability associated with autism: 5-15 mg/day.

Dosage adjustments may be required based on patient response, tolerability, and concurrent medications.

Administration

Aripra Tablet 15 mg is administered orally in tablet form, orally disintegrating tablet form, or liquid formulation. It is typically taken once daily, with or without food. Consistent daily dosing is important for maintaining therapeutic levels.

Side Effects

Common side effects include:

Nausea
Drowsiness
Insomnia
Weight gain
Dizziness

Serious side effects may include:

Extrapyramidal symptoms (e.g., tremor, rigidity)
Tardive dyskinesia
Neuroleptic malignant syndrome (NMS)
Increased risk of suicidal thoughts or behaviors

Toxicity

Toxicity from overdose may cause severe symptoms such as agitation, sedation, and hypotension. In cases of overdose, symptomatic and supportive treatment should be administered. Gastric lavage or activated charcoal may be considered if the overdose is recent.

Precautions

Precautions include:

Monitoring for signs of extrapyramidal symptoms or tardive dyskinesia.
Assessing metabolic status, including weight and glucose levels, as aripiprazole can contribute to weight gain and glucose dysregulation.
Regular monitoring of mood and behavior, especially in patients with a history of suicidal ideation.

Interaction

Interactions may occur with:

Other CNS depressants, which can enhance the sedative effects of aripiprazole.
Drugs that affect CYP2D6 or CYP3A4 enzymes, which can alter the metabolism of aripiprazole.
Antihypertensives, which may increase the risk of hypotension.

Disease Interaction

Use with caution in patients with:

Severe hepatic impairment
Severe renal impairment
Cardiovascular disease
History of seizures

Drug Interaction

Potential drug interactions include:

Strong CYP3A4 inhibitors (e.g., ketoconazole) or inducers (e.g., rifampin) which can significantly affect aripiprazole levels.
Other antipsychotics or dopamine agonists which may increase the risk of adverse effects.

Food Interactions

Food does not significantly affect the absorption or efficacy of aripiprazole. The medication can be taken with or without food.

Pregnancy Use

Aripra Tablet 15 mg should be used during pregnancy only if the potential benefits outweigh the risks. There is limited data on its use during pregnancy, and it may cause adverse effects on the fetus. Consult a healthcare provider to discuss risks and benefits.

Lactation Use

Aripra Tablet 15 mg is excreted in breast milk, and its effects on a nursing infant are not well understood. It is recommended to either discontinue breastfeeding or the medication, depending on the importance of the drug to the mother.

Acute Overdose

Acute overdose may lead to severe symptoms including sedation, agitation, and hypotension. Treatment includes symptomatic management and supportive care. Gastric lavage or activated charcoal may be used if the overdose is recent.

Contraindication

Contraindications include:

Hypersensitivity to aripiprazole or any of its components
Severe hepatic impairment (for certain formulations)

Use Direction

Follow the prescribed dosage and administration instructions. Regular follow-up appointments are essential to monitor the effectiveness and side effects of the medication. Adjustments should be made based on the healthcare provider's recommendations and patient response.

Storage Conditions

Store aripiprazole at room temperature, between 15°C and 30°C (59°F and 86°F). Keep the medication in its original container, away from moisture and light. Ensure it is kept out of reach of children.

Volume of Distribution

The volume of distribution of aripiprazole is approximately 4.9 L/kg.

Half Life

The terminal half-life of aripiprazole is approximately 75 hours, allowing for once-daily dosing. The extended half-life supports stable plasma levels over time.

Clearance

Aripra Tablet 15 mg is cleared primarily by hepatic metabolism. The clearance rate can be affected by factors such as liver function, age, and concomitant medications.

See in details version Aripra Tablet 15 mg also Aripra Tablet 15 mg in bangla